What is the recommended conversion dose from Adderall XR (amphetamine and dextroamphetamine) 30mg and Adderall IR (amphetamine and dextroamphetamine) 10mg to Focalin (dexmethylphenidate) for a patient with Attention Deficit Hyperactivity Disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting from Adderall XR 30mg + Adderall IR 10mg to Focalin

Direct Conversion Recommendation

Convert the total daily Adderall dose of 40mg (30mg XR + 10mg IR) to Focalin XR 20mg once daily in the morning, using a 2:1 conversion ratio that accounts for dexmethylphenidate's greater potency as the isolated d-enantiomer. 1

Conversion Rationale and Pharmacology

The 2:1 conversion ratio (Adderall to Focalin) is based on the pharmacological principle that dexmethylphenidate (Focalin) contains only the d-threo enantiomer of methylphenidate, which is the more pharmacologically active isomer. 1 This makes it approximately twice as potent per milligram compared to mixed amphetamine salts. 1

Key Conversion Steps:

  • Calculate total daily Adderall dose: 30mg XR + 10mg IR = 40mg total daily dose 2

  • Apply 2:1 conversion ratio: 40mg Adderall ÷ 2 = 20mg Focalin XR as starting dose 1

  • Choose extended-release formulation: Use Focalin XR rather than IR to replicate the coverage provided by the combination of Adderall XR and IR 1, 3

Titration Protocol After Conversion

Allow at least one week at the initial Focalin XR 20mg dose before making any adjustments to assess tolerability and therapeutic response. 4

  • If symptom control is inadequate after one week, increase by 5mg increments weekly up to a maximum of 40mg daily 1

  • The maximum recommended daily dose of Focalin XR is 40mg, which should not be exceeded 1, 2

  • Monitor for both efficacy and side effects at each dose adjustment using standardized ADHD rating scales 1

Critical Monitoring Requirements

Schedule follow-up within 2-4 weeks post-conversion to systematically assess response and tolerability. 5

Essential monitoring parameters include:

  • Cardiovascular monitoring: Check blood pressure and pulse at the first follow-up visit and quarterly thereafter 2, 1

  • Symptom assessment: Use standardized ADHD rating scales to objectively measure changes in core symptoms 1

  • Weight monitoring: Weigh patient at each visit to detect appetite suppression, a common stimulant side effect 4

  • Side effect surveillance: Assess for insomnia, decreased appetite, irritability, and cardiovascular effects 5, 1

Important Clinical Pitfalls to Avoid

Do not use a 1:1 conversion ratio, as this would result in overdosing given dexmethylphenidate's greater potency. 1

  • Avoid making dose adjustments more frequently than weekly, as insufficient time between changes prevents accurate assessment of therapeutic response 5

  • Do not crush or open Focalin XR capsules, as this destroys the extended-release mechanism and can cause dangerous immediate release of the full dose 2

  • If the patient was taking the Adderall IR 10mg dose in the afternoon for symptom coverage, ensure the Focalin XR provides adequate duration (typically 10-12 hours) 6, 3

  • Consider that some patients may require afternoon supplementation with Focalin IR 5mg if extended-release coverage is insufficient 1

Alternative Approach if Conversion Fails

If Focalin XR 20-40mg fails to provide adequate symptom control, switch to an alternative stimulant class rather than exceeding maximum recommended doses. 2

  • Consider returning to methylphenidate-based products (Concerta, Ritalin LA) if dexmethylphenidate is not well-tolerated 1

  • Non-stimulant options like atomoxetine or viloxazine may be appropriate if stimulant side effects are problematic 5, 7

  • The clinical team should reassess the diagnosis and consider comorbid conditions if multiple stimulant trials fail 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maximum Recommended Doses of Adderall XR and IR for ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adderall XR: long acting stimulant for single daily dosing.

Expert review of neurotherapeutics, 2004

Guideline

Adderall XR to Vyvanse Conversion Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Increased Reactivity on Adderall XR 5 mg

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

Journal of the American Academy of Child and Adolescent Psychiatry, 2003

Research

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

The Cochrane database of systematic reviews, 2018

Related Questions

What is the best course of action for managing a patient's 10-year Adderall (amphetamine and dextroamphetamine) 30mg XR treatment?
Is Adderall XR (amphetamine and dextroamphetamine) 20mg every morning plus Adderall IR (amphetamine and dextroamphetamine) 10mg once daily as needed (PRN) within a reasonable dosing range for managing Attention Deficit Hyperactivity Disorder (ADHD) symptoms?
What is the recommended dosing for Adderall (amphetamine and dextroamphetamine) XR in patients with attention deficit hyperactivity disorder (ADHD)?
What is the proper usage and dosage of Adderall (amphetamine and dextroamphetamine) for treating Attention Deficit Hyperactivity Disorder (ADHD)?
Does Vyvanse (lisdexamfetamine) last longer than Adderall XR (amphetamine and dextroamphetamine) in a patient currently taking Adderall XR 30 mg?
What are the primary treatment options for a patient with End-Stage Renal Disease (ESRD), including management of comorbid conditions and medication therapy?
Why is caffeine used in the in vitro contracture test (IVCT) for patients suspected of having malignant hyperthermia (MH) susceptibility?
What is the appropriate workup for an adult patient with newly diagnosed secondary hypertension and no prior history of hypertension?
What is the conversion ratio from intravenous (IV) fentanyl to IV Dilaudid (hydromorphone) for a patient with potential impaired renal or hepatic function?
What is the best course of treatment for a patient with abdominal and left lower quadrant pain after lifting, with unremarkable ultrasound findings, including normal abdominal aorta (AA), patent inferior vena cava (IVC), unremarkable pancreas, normal liver, gallbladder, and kidneys, and no evidence of masses, stones, or hydronephrosis?
What supplements are effective for treating neuropathic pain in patients, particularly those with diabetic neuropathy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.